Name:Hs.Cas9.GSDMB.1.AA Sequence:/AltR1/rGrG rArUrG rCrCrG rGrCrA rCrUrA rCrArC rArArC rGrUrU rUrUrA… and 2 more items

Integrated DNA Technologies Inc has been awarded a contract by the University of Virginia, effective July 25, 2026, with a cumulative value of $230. The contract is for the supply of Alt-R CRISPR-Cas9 complementary ribonucleic acid (crRNA) products, which are molecular biology reagents used in genetic research and development applications. The contract encompasses three distinct line items, each representing a unique crRNA sequence variant designated for the GSDMB gene target with specifications of 2 nanomole quantity and standard desalting purification methodology.

Each of the three line items is priced at $76.80 per unit with a quantity of one unit per item, for a total of three units across the award. All deliverables are specified to be delivered to Siyuan Wang at the University of Virginia in Virginia. The products supplied under this contract are standardized molecular biology reagents with 36 bases per sequence, typically utilized in clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing research. No specific period of performance or place of performance distinct from the contracting organization has been indicated in the available documentation.